Pacific Bio (PACB) Tops Q1 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $39.98 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ruanyun Edai Technology (RYET) files for 20M share offering by selling stockholders
• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%